SPRO financials
Spero Therapeutics (SPRO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- SPRO revenue was $66.80M in fiscal 2025, net income $8.57M.
SPRO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $66.80M | – | $6.31M | $8.57M | 0.15 |
| 2024 | $47.98M | – | -$73.36M | -$68.57M | -1.27 |
| 2023 | $103.78M | – | $21.48M | $22.81M | 0.43 |
| 2022 | $53.51M | – | -$42.20M | -$46.41M | -1.23 |
| 2021 | $18.26M | – | -$87.97M | -$89.76M | -2.91 |
| 2020 | $9.33M | – | -$79.11M | -$78.83M | -3.52 |